Innovative PCR-free biotechnology based on electrochemiluminescence for the early detection of viral infections by SARS-Cov-2
COVID-19 Response: to Detect, Mitigate and Destroy the virus
Although the world has slowed down due to the COVID-19 virus, research has never stopped! There are many technologies on the platform that can become a practical application within projects that aims to counteract the epidemic issues ranging from industrial reconversion to the search for solutions to fight the virus itself. Here you will find a collection of medical and non-medical technologies aimed at improving patient health and mitigating the spread of the virus.
In vitro test for quantification of neutralising antibodies activity in case of viral infection: assessment of immune response
Foam composition that prevents the formation of urine droplets and reduces the risk of infections by a very high percentage.
Novel elastic membrane designed ad hoc, without the need for new systems compared to those of common equipment.
Electrochemiluminescence analytical method for the quantification of RNA genomes of pathogenic microorganisms without PCR amplification.
Portable Point of Care control device for PCR, with automatic data transmission for epidemiological control purposes in real time.
Procedure capable of detecting, through the use of microwaves, the presence of viral agents present in a reference buffer solution.
In vitro method for predicting the risk or prognosis of a Covid-19 infection in overweight and / or obese subjects.
Leishmania tarentolae vaccine, engineered to express antigens that stimulate the production of coronavirus neutralizing antibodies.
Antiviral compounds that find application in the prevention and treatment of infections caused by coronavirus.
Use of the Leishmania protozoan for the development of serological tests for the diagnosis of Coronaviridae virus infections.
DNA aptamers capable of masking the binding site of SAR-CoV-2 to the cell and block the spread of the coronavirus.
Device that allows reducing, in combination with effective ventilation, the risk of contagion in indoor spaces operating at a short distance.
Solution to the high oxygen demand associated with ventilatory support therapies which doesn't need any connection to the hospital gas network.
Air quality control sampling device to help identify the presence of pathogens, such as the SARS-CoV-2 virus.
New synthetic molecules capable of blocking the inflammatory cascade at the root, selectively blocking the TLR4 receptor.
Diagnostic kit for the multiple detection of 4 viruses of the Coronaviridae family: HCoV, SARS-CoV, MERS-CoV and the SARS-CoV-2 viral strain.
Vesicular systems formed by double-structure asymmetric bilayers for the delivery of genetic material
Asymmetric vesicles to carry genetic material for anticancer therapies, vaccines and for the treatment of genetic diseases.
Methodology for assessing the risk of environmental contamination of indoor/closed spaces by airborne pathogens.
The invention offers a vaccine that induces a strong antibody response against HPV type 16 antigens and for the SARS-CoV protein N.
Molecular target, for the development of innovative therapies in diseases characterized by excessive and unwanted neovascularization
System designed for the sanitation of the external surface of food packages, as well as tools for food processing.
Biosensor capable of specifically detecting the entire SARS-CoV-2 using an engineered version of the human ACE2 receptor.
Voice analysis for investigating a patient's state of health, in particular to facilitate the diagnosis of diseases and / or disorders.
Compounds of formula I, their combination with a further antiviral agent and relative pharmaceutical compositions to combat enveloped viruses.
Method for the rapid assay of SARS-CoV-2 infection by direct detection of at least one virus protein in a biological fluid sample.
Universal 3D substrate with a buildable gradient of gas and nutrients for bacterial culture and screening of antimicrobial agents.
Nanostructures capable of carrying oxygen, gas and contrast agents into hypoxic tissues, for diagnostic or therapeutic purposes.
Nanoparticles capable of delivering different types of drugs to fight infectious diseases and counteract antimicrobial resistance.
Aquatic masks converted into masks with continuous positive airway pressure (CPAP), to improve the respiratory capacity of patients.
Epigenetic drugs and targets effective against the virus replicative cycle that will also help to design more effective therapies for the pandemic.
System able to inform the clinicians about patient's AKI in real time and remotely thanks to proprietary Artificial Intelligence algorthms.
Liposomes composition which, applied in dosing methods, enables to obtain higher sensitivity, lower costs and higher semplicity to perform the test.
Technique which allows the identification of new molecular targets for the design of new drugs for the early treatment of viral infections.
Invention that aims to identify antiviral drugs for the treatment of Herpesvirus infection, in order to enable the inhibition of viruses' replication.
Label to monitor the products' conservation conditions through the monitoring of material's properties related the Time / Temperature ratio.
Invention means to control the growth of pathogenic bacteria, standing up as an innovative biotech solution for industrial and medical applications.
Assay to quantify extracellular NAPRT levels in biological fluids to be used as marker in inflammatory/metabolic conditions.
Host cell protein involved in the replication of a virus of the Herpesviridae family employed as antiviral against viruses of the Herpesviridae family.
Particles that can act as a carrier to transport/release substances or drug, by contrast in diagnostics or as a stimulus in bone regeneration.
Adrenaline-encapsulated liposomes able to keep the required therapeutic dose constant for longer time and to reduce therapy's critical side effects.
Technology able to sterilize bulk or pre-packaged items in blisters, through the indirect action of a non-thermal plasma.
Invention to both detect and track people in indoor environments, and to establish whether a person is standing, sitting, or has fallen.
System based on inertial sensors allowing the remote control of fundamental temporal respiratory parameters.
Device to measure the activation degree of the gustatory system through the registration of the bio-potentials resulting from the repsonce to a stimulus.
An innovative method for the treatment of patients undergoing mechanical ventilation that allows lung damage prevention.
Implantable device for the hemolysis early diagnosis of heart aid implanted patients (VAD, Ventricular Assistive Device).
Innovative coating consisting of a glass matrix and metal nanoparticles that can be modulated according to different applications.
Instrument for automatic analysis and recognition (through a software/algorithm) of pulmonary sounds acquired through an electronic stethoscope.